Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Long-term changes in adiposity and glycemic control are associated with past adenovirus infection.

Lin WY, Dubuisson O, Rubicz R, Liu N, Allison DB, Curran JE, Comuzzie AG, Blangero J, Leach CT, Göring H, Dhurandhar NV.

Diabetes Care. 2013 Mar;36(3):701-7. doi: 10.2337/dc12-1089. Epub 2012 Nov 16.

2.

Tracking Study About Adenovirus 36 Infection: Increase of Adiposity.

Park S, Kim J, Shin HJ, Hong YM, Sheen YH, Park HL, Jeon HJ, Ahn SY, Nam JH.

J Microbiol Biotechnol. 2015 Dec 28;25(12):2169-72. doi: 10.4014/jmb.1509.09003.

3.

Template to improve glycemic control without reducing adiposity or dietary fat.

Krishnapuram R, Dhurandhar EJ, Dubuisson O, Kirk-Ballard H, Bajpeyi S, Butte N, Sothern MS, Larsen-Meyer E, Chalew S, Bennett B, Gupta AK, Greenway FL, Johnson W, Brashear M, Reinhart G, Rankinen T, Bouchard C, Cefalu WT, Ye J, Javier R, Zuberi A, Dhurandhar NV.

Am J Physiol Endocrinol Metab. 2011 May;300(5):E779-89. doi: 10.1152/ajpendo.00703.2010. Epub 2011 Jan 25.

4.

Human obesity relationship with Ad36 adenovirus and insulin resistance.

Trovato GM, Castro A, Tonzuso A, Garozzo A, Martines GF, Pirri C, Trovato F, Catalano D.

Int J Obes (Lond). 2009 Dec;33(12):1402-9. doi: 10.1038/ijo.2009.196.

PMID:
19786969
5.

Accurate identification of neutralizing antibodies to adenovirus Ad36, -a putative contributor of obesity in humans.

Dubuisson O, Day RS, Dhurandhar NV.

J Diabetes Complications. 2015 Jan-Feb;29(1):83-7. doi: 10.1016/j.jdiacomp.2014.09.004. Epub 2014 Sep 16.

PMID:
25312598
6.

Adenovirus 36 attenuates weight loss from exercise but improves glycemic control by increasing mitochondrial activity in the liver.

Na HN, Hong YM, Ye MB, Park S, Kim IB, Nam JH.

PLoS One. 2014 Dec 5;9(12):e114534. doi: 10.1371/journal.pone.0114534. eCollection 2014.

7.

Adenovirus-36 seropositivity enhances effects of nutritional intervention on obesity, bright liver, and insulin resistance.

Trovato GM, Martines GF, Trovato FM, Pirri C, Pace P, Garozzo A, Castro A, Catalano D.

Dig Dis Sci. 2012 Feb;57(2):535-44. doi: 10.1007/s10620-011-1903-8. Epub 2011 Sep 28.

PMID:
21953137
8.

Human adenovirus-36 is uncommon in type 2 diabetes and is associated with increased insulin sensitivity in adults in Sweden.

Almgren M, Atkinson RL, Hilding A, He J, Brismar K, Schalling M, Ostenson CG, Lavebratt C.

Ann Med. 2014 Nov;46(7):539-46. doi: 10.3109/07853890.2014.935469. Epub 2014 Jul 21.

PMID:
25045929
9.

Ad36 adipogenic adenovirus in human non-alcoholic fatty liver disease.

Trovato GM, Martines GF, Garozzo A, Tonzuso A, Timpanaro R, Pirri C, Trovato FM, Catalano D.

Liver Int. 2010 Feb;30(2):184-90. doi: 10.1111/j.1478-3231.2009.02127.x. Epub 2009 Oct 13.

PMID:
19840251
10.

Association of adenovirus 36 infection with obesity and metabolic markers in humans: a meta-analysis of observational studies.

Yamada T, Hara K, Kadowaki T.

PLoS One. 2012;7(7):e42031. doi: 10.1371/journal.pone.0042031. Epub 2012 Jul 25.

11.

Longitudinal investigation of adenovirus 36 seropositivity and human obesity: the Cardiovascular Risk in Young Finns Study.

Sabin MA, Burgner D, Atkinson RL, Pei-Lun Lee Z, Magnussen CG, Cheung M, Kähönen M, Lehtimäki T, Jokinen E, Laitinen T, Hutri-Kähönen N, Viikari JS, Juonala M, Raitakari OT.

Int J Obes (Lond). 2015 Nov;39(11):1644-50. doi: 10.1038/ijo.2015.108. Epub 2015 Jun 9.

PMID:
26055076
12.

Comment on: Lin et al. Long-term changes in adiposity and glycemic control are associated with past adenovirus infection. Diabetes Care 2013;36:701-707.

Trovato GM, Catalano D, Martines GF, Trovato FM.

Diabetes Care. 2013 Oct;36(10):e184. doi: 10.2337/dc13-0671. No abstract available.

13.

Comment on: Lin et al. Long-term changes in adiposity and glycemic control are associated with past adenovirus infection. Diabetes Care 2013;36:701-707.

Yamada T, Hara K, Kadowaki T.

Diabetes Care. 2013 Sep;36(9):e161. doi: 10.2337/dc13-0657. No abstract available.

15.

Association of adenovirus 36 infection with adiposity and inflammatory-related markers in children.

Berger PK, Pollock NK, Laing EM, Warden SJ, Hill Gallant KM, Hausman DB, Tripp RA, McCabe LD, McCabe GP, Weaver CM, Peacock M, Lewis RD.

J Clin Endocrinol Metab. 2014 Sep;99(9):3240-6. doi: 10.1210/jc.2014-1780. Epub 2014 Jun 13.

16.

Response to Comment on: Lin et al. Long-term changes in adiposity and glycemic control are associated with past adenovirus infection. Diabetes Care 2013;36:701-707.

Lin WY, Dubuisson O, Rubicz R, Liu N, Allison DB, Curran JE, Comuzzie AG, Blangero J, Leach CT, Göring H, Dhurandhar NV.

Diabetes Care. 2013 Sep;36(9):e162. doi: 10.2337/dc13-0879. No abstract available.

17.

Adenovirus 36 antibodies associated with clinical diagnosis of overweight/obesity but not BMI gain: a military cohort study.

Voss JD, Burnett DG, Olsen CH, Haverkos HW, Atkinson RL.

J Clin Endocrinol Metab. 2014 Sep;99(9):E1708-12. doi: 10.1210/jc.2014-1863. Epub 2014 Jun 27.

18.

Role of adenoviruses in obesity.

Voss JD, Atkinson RL, Dhurandhar NV.

Rev Med Virol. 2015 Nov;25(6):379-87. doi: 10.1002/rmv.1852. Epub 2015 Sep 9. Review.

PMID:
26352001
19.

Body adiposity and type 2 diabetes: increased risk with a high body fat percentage even having a normal BMI.

Gómez-Ambrosi J, Silva C, Galofré JC, Escalada J, Santos S, Gil MJ, Valentí V, Rotellar F, Ramírez B, Salvador J, Frühbeck G.

Obesity (Silver Spring). 2011 Jul;19(7):1439-44. doi: 10.1038/oby.2011.36. Epub 2011 Mar 10.

20.

Adenovirus 36, adiposity, and bone strength in late-adolescent females.

Laing EM, Tripp RA, Pollock NK, Baile CA, Della-Fera MA, Rayalam S, Tompkins SM, Keys DA, Lewis RD.

J Bone Miner Res. 2013 Mar;28(3):489-96. doi: 10.1002/jbmr.1776.

Supplemental Content

Support Center